Introduction
Protein/protein interaction is the leitmotif in receptor tyrosine kinase (PTK) and tyrosine kinase-coupled receptor signaling. Receptor engagement initiates a tyrosine phosphorylation cascade, the outcome of which is not only sequential activation of additional PTKs, but also recruitment to the submembrane region of the activated receptor of a number of signaling molecules containing phosphotyrosine interaction domains (reviewed in Pawson, 1995) . In T-cells, a number of molecules interacting directly or indirectly with the activated T-cell antigen receptor (TCR) have been identi®ed. Several of these are enzymes, and include tyrosine kinases (e.g. ZAP-70, Syk, Fyn and Lck), enzymes involved in membrane phospholipid breakdown and modi®cation (e.g. phospholipase Cg and PI-3 kinase) and guanine nucleotide exchange factors (e.g. Sos, Vav) (reviewed in Weiss and Littman, 1994; Wange and Samelson, 1996) . However, many of the signaling molecules recruited to the activated TCR are devoid of intrinsic enzymatic activity and appear only to promote multiple protein/protein interactions. These molecular adaptors, which in T-cells include SLP-76, LAT, Shc and Grb-2, are composed of a combination of a limited array of distinct protein/protein interaction domains (reviewed in Peterson et al., 1998; Rudd, 1999) . Interestingly, one or more of these domains are present in all the enzymes involved in early signaling, suggesting that they also function as adaptors.
An important outcome of the change in subcellular localization resulting from protein/protein interaction is regulation of protein activity. For example, the kinase activity of ZAP-70 is strongly upregulated following binding to the tyrosine phosphorylated z chain ITAMs of the TCR/CD3 complex (Iwashima et al., 1994; Neumeister et al., 1995) . In some instances however protein redistribution provides a means for functionally interdependent proteins to reach physical proximity. The paradigm of this mechanism of regulation of protein activity is Ras. The activity of Ras is modulated by guanine nucleotide binding. To reach the active state, Ras must exchange GDP with GTP, and this reaction is catalyzed by guanine nucleotide exchange factors, of which the best characterized is Sos. As a result of post-translational farnesylation, Ras is localized in the plasma membrane, while Sos is prevalently cytosolic. For Ras to be activated, Sos must be brought to the cytosolic side of the plasma membrane close to Ras. This is achieved by the small adaptor Grb-2, which is composed of a central SH2 domain and of two SH3 domains, which have a high anity for Sos. Grb-2 has also a cytosolic location, but is recruited to the activated receptor through its SH2 domain and thus permits translocation of Sos in proximity of the membrane, where it can activate Ras (reviewed in McCormick, 1993) . Although Grb-2 can bind directly to the tyrosine phosphorylated z chain ITAMs following TCR engagement, it can also be indirectly recruited to the activated TCR by other adaptors, such as Shc and LAT (reviewed in Koretzky, 1997) , suggesting that these adaptors might cooperate to build a critical threshold of Ras activation. Alternatively, they might serve to ensure the successful activation of Ras by providing multiple redundant Ras activation pathways.
The Shc adaptor has a multidomain structure which potentially permits its participation in multiple distinct interactions. Shc is composed of a central CH domain, anked by two phosphotyrosine interacting domains with dierent binding speci®city, an N-terminal PTB domain and a C-terminal SH2 domain. Phosphorylation of three tyrosine residues (239/240 and 317) at two distinct sites in the CH domain results in the generation of two independent Grb-2 docking sites (reviewed in Bon®ni et al., 1996; Baldari and Telford, 1999) . Recent reports suggest that phosphorylation at tyrosine 317 is the principal event that leads to Shc mediated activation of the Ras pathway (Gotoh et al., 1996) . However, there is evidence that phosphorylation at tyrosines 239 and 240 may also contribute to Ras activation, possibly as a result of a cooperation of both Grb-2 binding sites in stabilizing Sos in a membraneproximal localization (Harmer and DeFranco, 1997) . In T-cells, Shc is phosphorylated on tyrosine residues following TCR triggering, and in that state not only binds Grb-2/Sos complexes, but furthermore enhances the association between Grb-2 and Sos (Ravichandran et al., 1993 (Ravichandran et al., , 1995 Baldari et al., 1995) . Recruitment of Shc to the activated TCR is achieved through a dual interaction with z chain-bound ZAP-70 through the PTB domain (Milia et al., 1996) , and with the z chain itself through the SH2 domain (Ravichandran et al., 1993) , potentially resulting in enhanced stability of Shc/Grb-2/Sos complexes at the activated TCR.
TCR signal transduction has been recently shown to be dependent on receptor recruitment to lipid rafts (Montixi et al., 1998; Xavier et al., 1998) . These are detergent resistant plasma membrane microdomains highly enriched in cholesterol and glycosphingolipids, where key signaling molecules posttranslationally modi®ed by addition of a lipid moiety, such Ras and Src family PTKs, reside (reviewed in Simons and Ikonen, 1997; Magee and Marshall, 1999) . Following ligand binding, the activated TCR colocalizes in lipid rafts together with ZAP-70 and Syk, which are recruited to the tyrosine phosphorylated ITAMs from their otherwise cytosolic localization (Montixi et al., 1998; Xavier et al., 1998) . Also the Shc adaptor inducibly localizes in the rafts following TCR triggering (Xavier et al., 1998) , suggesting that raft localization might be required for Shc activity. Here we show that addition to Shc of the membrane localization sequence from Ras resulted in constitutive Shc localization at the plasma membrane, with a distribution largely con®ned to lipid rafts. Membrane targeted Shc was constitutively phosphorylated on tyrosine residues, thus bypassing the requirement for TCR triggering. Expression of membrane targeted Shc resulted in constitutive activation of the Ras/MAP kinase pathway and in enhanced response of the NF-AT transcription factor to TCR triggering. These eects were dependent on the integrity of the two Grb-2 binding sites in the Shc CH domain. The data show that localization in membrane rafts is sucient for Shc to acquire a fully signaling competent state.
Results

Membrane targeting of Shc by addition of the Ras CAAX motif results in constitutive Shc localization in lipid rafts
The CAAX motif of Ras has been shown to be sucient for protein farnesylation and targeting to the cytosolic side of the plasma membrane (Hancock et al., 1991) . The speci®c localization of Ras in the detergentresistant membrane subcompartment (Simons and Ikonen, 1997; Xavier et al., 1998) suggests that the Ras membrane localization motif might also be sucient for targeting Ras to the membrane rafts. The cDNA encoding a Shc hybrid protein tagged at the N-terminus with an epitope from in¯uenza hemagglutinin (HA-Shc) was engineered to express at the C-terminus the Ras CAAX motif (HA-Shc-MLS; Figure 1a ). The chimeric cDNA was cloned into a mammalian expression vector under the control of a strong constitutively active promoter and stably transfected into Jurkat T cells. Figure 1b shows an immunoblot analysis with an anti-HA mAb of total cells lysates from the stable transfectants. Immunoreactive proteins of the expected molecular size were detectable in total lysates of cells transfected with the HA-Shc constructs, but not in the parental line. The identity of these proteins was con®rmed by reprobing the stripped ®lter with anti-Shc antibodies (data not shown). Flow cytometric analysis with anti-CD3 mAb showed that TCR/CD3 expression was comparable in all cell lines (data not shown).
Lysates of cells stably transfected with HA-Shc-MLS or HA-Shc were fractionated into cytoplasmic and Figure 2 , HA-Shc-MLS was mostly found in the membrane fraction, while HA-Shc could only be detected in the cytosolic fraction, con®rming that the Ras CAAX motif, fused to the Cterminus of Shc, resulted in constitutive localization of Shc at the plasma membrane. To establish whether the Ras CAAX motif was also sucient for protein localization in the detergent-resistant membrane microdomains, lipid rafts were isolated by sucrose gradient centrifugation from lysates of cells expressing either HA-Shc or HA-Shc-MLS. Light fractions, enriched in rafts, and heavy fractions, containing most detergent soluble proteins, were tested by immunoblot with anti-Shc antibodies. As shown in Figure 3 , three bands immunoreactive to anti-Shc antibodies were detected in both cell lines, of which the lowest two correspond to the two Shc isoforms found in T-cells (p52 and p46), while the uppermost corresponds to the chimeric Shc proteins. The identity of the latter band was con®rmed by probing similar samples with anti-HAantibodies ( Figure 3 , top panel). In both cell lines endogenous Shc is only detectable in the heavy fractions, showing that, in the absence of TCR triggering, the localization of Shc is largely cytosolic. However, while HA-Shc colocalizes with endogenous Shc in the detergent-soluble fractions, most of HA-Shc-MLS is found in the light fractions (Figure 3) , showing that addition of the CAAX motif results in constitutive localization of Shc in lipid rafts. Importantly, probing the stripped ®lter with anti-Lck or anti-phosphotyrosine antibodies showed a strict compartmentalization in membrane rafts of Lck and presumably of other PTKs with a basal activity sucient to phosphorylate a number of protein substrates.
HA-Shc-MLS is constitutively phosphorylated and activates the Ras/MAPK pathway in the absence of TCR triggering
The colocalization of membrane targeted Shc and tyrosine kinases in the rafts suggests the possibility that Shc might be phosphorylated, and hence signaling competent, even in the absence of TCR engagement. To test this possibility, HA-Shc and HA-Shc-MLS were immunoprecipitated from lysates of the respective transfectants with an anti-HA mAb and probed by immunoblot with anti-phosphotyrosine antibodies. As shown in Figure 4a , while HA-Shc was only phosphorylated following TCR triggering, HA-Shc-MLS was fully phosphorylated in the absence of stimulation. Similar experiments showed that HAShc-MLS was constitutively associated with Grb-2 ( Figure 4b ) and Sos (data not shown). In support for a role for tyrosine phosphorylated Shc in Grb-2/Sos complex formation (Ravichandran et al., 1995; Harmer and DeFranco, 1997) , high levels of constitutive Figure 4C ). Hence targeting Shc to the plasma membrane results in constitutive Shc phosphorylation on tyrosine residues and association with Grb-2/Sos complexes.
Ras activation marks the transition from a tyrosine kinase to a serine/threonine kinase cascade where MAP kinases play a major role. Erk2, one of the most distal among the MAP kinases, is regulated by phosphorylation on both serine and tyrosine residues (reviewed in Marshall, 1994) . To test whether targeting Shc to the membrane, and the resulting constitutive recruitment of Grb-2/Sos complexes, was sucient for triggering the MAP kinase pathway, Erk2 was immunoprecipitated from lysates of cells expressing HA-Shc or HAShc-MLS, and probed with anti-phosphotyrosine antibodies. As shown in Figure 5a , Erk2 was constitutively phosphorylated in cells expressing HAShc-MLS in the absence of stimulation, although maximal levels of phosphorylation were only achieved following TCR triggering. Similar results were obtained in immune complex kinase assays (data not shown). Interestingly, no eect of HA-Shc-MLS was detected on the activation of p38, a member of the stress activated MAP kinases, as revealed by immunoblot with anti-phospho-p38 MAPK antibodies (Figure 5b) . Collectively, these data suggest that regulation of the Ras/MAP kinase pathway through Shc relies solely on a change in the subcellular localization of Shc from the cytosol to the plasma membrane, and its subsequent phosphorylation on tyrosine residues.
Following TCR engagement, Shc interacts both with ZAP-70 and with the tyrosine phosphorylated z chain of the TCR/CD3 complex. The association between Shc and ZAP-70 is required for downstream signaling (Ravichandran et al., 1993; Milia et al., 1996; . Interestingly, a 70 kDa phosphoprotein, which was identi®ed as ZAP-70 by immunoblot, coimmunoprecipitated with both HA-Shc and HAShc-MLS only following TCR triggering (Figure 4a ), in agreement with a relocalization of ZAP-70 in the rafts following receptor engagement (Montixi et al., 1998; Xavier et al., 1998) . A similar inducible association was observed with the tyrosine phosphorylated CD3 z chain (data not shown). Hence targeting Shc to the membrane bypasses the interactions normally required in Shc relocalization to the membrane following TCR engagement. Furthemore, membrane targeted Shc is phosphorylated independently of ZAP-70 recruitment to the rafts, suggesting that, although the primary PTK responsible for Shc phosphorylation is ZAP-70 Walk et al., 1998) , another PTK resident in the rafts, such as Lck, can take over this function.
Enhancement of TCR dependent activation of the transcription factor NF-AT by membrane targeted Shc
The transcription factor NF-AT, which is responsible for the response of the IL-2 gene promoter to TCR generated signals, can be fully activated in response to TCR engagement in the absence of additional stimuli and is thus an attractive read-out of productive TCR signaling (reviewed in Crabtree and Clipstone, 1994) . To test the eect of membrane targeting of Shc on TCR dependent gene expression, Jurkat transfectants expressing HA-Shc or HA-Shc-MLS, as well as the parental line, were transiently transfected with a reporter construct encoding ®re¯y luciferase under the control of a trimer of the distal NF-AT binding site of the IL-2 promoter, and activated by TCR engagement using anti-CD3 mAb. As shown in Figure 6 , luciferase activity was increased by 200% in cells expressing HAShc-MLS as compared to parental cells, while HA-Shc had no signi®cant eect. Since a constitutively active mutant of Ras can synergize with a calcium ionophore in inducing NF-AT activation (Baldari et al., 1993; Woodrow et al., 1993a) , cells were also activated with the calcium ionophore A23187. No signi®cant luciferase activity was observed in the absence of stimulation or in the presence of A23187 in any of the lines (data not shown). Hence localization of Shc to the plasma membrane enhances signaling from the TCR, but is not sucient for full activation of the Ras pathway. Interestingly, the levels of Ras activity achieved by membrane targeted Shc were sucient for ecient activation of Erk2 to levels close to the ones induced following TCR triggering (Figure 5a ), suggesting that additional eectors downstream of Ras are required for NF-AT activation. Expression of a constitutively active Erk2 mutant has indeed been shown not to be sucient for Ras-dependent NF-AT activation, although Erk2 appears to be one of the key eectors downstream of Ras required for full activation of this pathway (Genot et al., 1996) .
The Grb-2 binding sites are required for enhancement in TCR signaling by membrane targeted Shc
In addition to binding Grb-2/Sos on the two major phosphorylation sites Y239/240 and Y317, Shc can potentially interact with a number of proteins in Tcells, both through the two phosphotyrosine interacting domains (Ulivieri et al., 1999) , and through the unphosphorylated CH domain (Pacini and Baldari, unpublished data) . These additional, Grb-2/Sos independent, interactions might contribute to the enhancement in TCR signaling observed following targeting Shc to the plasma membrane. To assess this possibility, we generated a triple substitution mutant where tyrosines 239, 240 and 317 were replaced by phenylalanine residues (HA-3FShc-MLS; Figure 1a ). This mutant was cloned in a mammalian expression vector and used to generate a stable Jurkat transfectant expressing high levels of chimeric protein as described above (Figure 1b) . The chimeric protein was correctly localized in lipid rafts ( Figure 7a ). As expected, an immunoblot with anti-phosphotyrosine antibodies of HA-3FShc-MLS immunoprecipitated with anti-HA mAb showed that this mutant was not phosphorylated on tyrosine residues either in the absence of cell stimulation or following TCR triggering (Figure 7b ). The lack of phosphorylation is likely to underlie the slightly higher electrophoretic mobility of this mutant as compared to HA-Shc-MLS (Figure 1 ). HA-3FShc-MLS was however still capable of inducibly associating with ZAP-70 ( Figure 7b ) and tyrosine phosphorylated CD3z (data not shown).
Cells expressing HA-3FShc-MLS, as well as control cells expressing HA-Shc, were transiently transfected with the NF-AT/luciferase reporter and activated with anti-CD3 mAb. As shown in Figure 7c , no enhancement in TCR dependent NF-AT activation was observed in the presence of HA-3FShc-MLS, suggesting that the enhancement in TCR signaling resulting from targeting Shc to the plasma membrane is not dependent on interactions other than those involving the Grb-2 binding sites. Interestingly, not only is the enhancement abrogated, but a signi®cant reduction in TCR dependent NF-AT activation was observed in To assess this point, we investigated the activation status of the most downstream component of the Ras/ MAP kinase pathway, Erk2. Erk2 was immunoprecipitated from lysates of cells expressing either HA-Shc or HA-3FShc-MLS and probed by immunoblot with anti-phosphotyrosine antibodies. As shown in Figure  8a , no costitutive Erk2 phosphorylation was detectable in cells expressing HS-3FShc-MLS as compared to control cells. Furthermore, expression of HS-3FShc-MLS resulted in a signi®cant reduction in tyrosine phophorylation of Erk2 as compared to HA-Shc. A possible explanation of the dominant negative eect of this mutant is a competitive inhibition of endogenous Shc recruitment to ZAP-70 and phospho-z. This could be achieved by constitutive localization of HA-3FShc-MLS in the rafts, which would place it in a favorable position, with respect to endogenous Shc, for interacting with the molecules responsible for Shc recruitment to the same sites. In agreement with the lack of p38 MAPK modulation by membrane targeted Shc, expression of HA-3FShc-MLS did not aect TCR inducible p38 MAPK activation (Figure 8b) .
The transdominant negative eect of the HA-3FShc-MLS mutant on Erk2 and NF-AT activation suggests a non redundant role for Shc in the activation of Ras through recruitment of Grb-2/Sos complexes. A number of other proteins have however been shown to interact with Grb-2 in activated T-cells. Among these, the LAT adaptor is critically required for productive TCR signaling (Zhang et al., 1998) . To rule out the possibility that the impaired response to TCR triggering in cells expressing the HA-3FShc-MLS mutant might result from a defect in LAT, the levels of LAT expression and phosphorylation following TCR engagement were determined in these cells. Immunoblot analysis with anti-LAT antibodies showed that LAT was expressed at normal levels in all three stably transfected Jurkat lines (data not shown). Furthermore, no dierence in TCR dependent LAT phosphorylation was detectable as compared to cells transfected with HA-Shc or HA-Shc-MLS (Figure 8c and data not shown), reinforcing a speci®c requirement for Shc in Ras activation in T-cells.
Discussion
Forced membrane proximity of signaling proteins induced either by engineering of a membrane localization sequence or by chemical inducers of dimerization has proved a powerful strategy in the study of the mechanisms controlling protein function. A remarkable example is ZAP-70. ZAP-70 recruitment involves ZAP-70 binding through its tandem SH2 domains to the doubly phosphorylated CD3z chain ITAMs, resulting both in a conformational change and in ZAP-70 localization close to Lck (Iwashima et al., 1994; Neumeister et al., 1995; Duplay et al., 1994) . These two events contribute to enhancing the kinase activity of ZAP-70, which subsequently autophosphorylates on a number of tyrosine residues, permitting its association with many signaling proteins (Neumeister et al., 1995) . This complex mechanism of ZAP-70 recruitment and activation can be completely bypassed by membrane targeting of ZAP-70, and indeed the SH2 domains of ZAP-70 have been shown to be dispensable to the activity of membrane-targeted ZAP-70 (Yamasaki et al., 1996; Graef et al., 1997) , suggesting that redistribution of ZAP-70 from a cytosolic to a membrane-proximal localization is the main means of regulation of ZAP-70 function. Similarly, forced membrane localization has provided important insight into the regulation of Sos. Membrane targeted Sos can in fact activate the Ras/MAP kinase pathway independently of its interaction with Grb-2, showing that Sos function is modulated by membrane recruitment and not by allosteric changes (Aronheim et al., 1994; Holsinger et al., 1995) .
Our data show that, also in the case of Shc, recruitment of Shc to the activated TCR does not imply a conformational change, and that membrane proximity is sucient for function. In this respect, although a small fraction of Shc has been found associated to total cellular membranes in T-cells (Ravichandran et al., 1997) , the capacity of Shc to interact with phospholipids through its PTB domain does not appear to permit a stable localization of Shc at the plasma membrane, although it might contribute to stabilizing Shc in a membrane-proximal localization following recruitment to activated receptors, as reported for the PH domain of Sos (Chen et al., 1997) . Interestingly, ablation of the two Grb-2 binding sites results in complete abrogation of the constitutive eects elicited by membrane targeted Shc, suggesting that these eects depend on successful activation of the Ras pathway by Grb-2/Sos recruitment, and not on additional Grb-2-independent pathways involving Shc interaction with other signaling proteins. Interestingly, targeting of Grb-2 to the membrane did not result in downstream signaling (Holsinger et al., 1995) . Although it is possible that membrane targeted Grb-2 is not in a favorable conformation for the formation of complexes with Sos, another possibility which could account for this ®nding is that optimal Sos recruitment might require its association with more than one Grb-2 molecule. In this case the spatial distribution of Grb-2 at the cytosolic side of the plasma membrane might be crucial, and Shc has indeed been proposed to contribute to Ras activation by permitting a dual interaction of one Sos molecule to two CH domainbound Grb-2 molecules, thereby stabilizing Sos close to the plasma membrane (Harmer and DeFranco, 1997).
Recruitment of Grb-2/Sos complexes by Shc requires tyrosine phosphorylation of Shc, and this condition is met, even in the absence of TCR triggering, by targeting Shc to the plasma membrane. This can be accounted for by the constitutive localization of membrane targeted Shc in the detergent-resistant membrane rafts, where Shc inducibly localizes in response to TCR engagement (Xavier et al., 1998) . Lipid rafts are highly enriched in Src family PTKs, and speci®cally Lck (Montixi et al., 1998; Xavier et al., 1998) , which has been shown to be responsible for Shc phosphorylation following CD4 triggering and to contribute to full Shc phosphorylation by ZAP-70 following TCR triggering (Baldari et al., 1995; Walk et al., 1998) . Although Y239 and Y240 are preferentially phosphorylated by ZAP-70, they can be also phosphorylated by Lck (Walk et al., 1998) . This suggests that bypassing Shc recruitment to the rafts by binding ZAP-70 through the PTB domain, and phospho-z through the SH2 domain, can result in Shc phosphorylation by Lck alone. Interestingly, the adaptors responsible for recruitment of Grb-2/Sos complexes are either resident in the lipid rafts (e.g. LAT; Zhang et al., 1998) or inducibly colocalize in these membrane subregions together with the activated TCR (e.g. Shc; Xavier et al., 1998) . Furthermore, Ras is constitutively localized in the rafts (Xavier et al., 1998) . Hence a high local concentration of Grb-2/Sos complexes in proxiOncogene Constitutive activation of the Ras/MAPK pathway by membrane targeted Shc S Plyte et al mity of Ras is likely to be achieved following TCR triggering, permitting ecient activation of Ras.
While membrane targeted Shc appears to be in a fully signaling competent state, it only enhanced the NF-AT activity induced by TCR triggering, but failed to synergize with a calcium ionophore. Conversely, we and other have previously shown that an oncogenic, constitutively active Ras mutant strongly synergized with an increase in intracellular free calcium and reconstituted full NF-AT activation (Baldari et al., 1993; Woodrow et al., 1993a) . One possibility is that, while the Ras mutant used in these studies lacked GTPase activity and was thus permanently in the active state, localization of Shc to the membrane triggers the physiological pathway of Ras activation, implying repeated cycles of upregulation and downregulation of Ras activity and a net Ras activity under a critical threshold. Another possibility is that the pathways of Ras activation in T-cells involving recruitment to the membrane of Grb-2/Sos complexes are not redundant, but that they cooperate to achieve the threshold of Ras activity required for NF-AT activation. The latter possibility is supported by the dominant negative eect of the membrane targeted Shc mutant lacking both Grb-2 binding sites on the activation of downstream eectors of Ras, including Erk2 and NF-AT. Transdominant inhibition of NF-AT was also shown for truncation mutants of Shc containing the isolated phosphotyrosine interacting domains (Baldari et al., 1995; Milia et al., 1996) . Hence, notwithstanding alternative pathways for recruitment of Grb-2/Sos complexes to Ras, the pathway involving Shc is not redundant.
Materials and methods
Plasmids and antibodies
The cDNA encoding HA-tagged Shc (a gift of T Pawson) was cloned as an HindIII ± XbaI fragment into pBluescript (Stratagene GmbH, Heidelberg, Germany). PCR primers spanning the sequence encoding C-terminal SH2 domain of Shc, and incorporating an internal PstI site, were designed. The antisense primer included a mutation at the Shc stop codon and the sequence encoding nine amino acids of the Ras CAAX motif together with a new stop codon and an XbaI site. This fragment (SH2-MLS) was ampli®ed by PCR from a full length Shc cDNA and cloned into pBs-HA-Shc as a PstI ± XbaI fragment, thereby replacing the native SH2 domain, to create pBs-HA-Shc-MLS. This was then subcloned into the mammalian expression vector pcDNA3 (Invitrogen, Leek, Netherlands) under the control of the CMV enhancer as an HindIII ± XbaI fragment. The 3FShc mutant was generated by M13-based, oligonucleotide-directed site-speci®c mutagenesis of Shc cDNA using standard procedures. NF-AT/luc contains a trimer of the NF-AT binding site of the IL-2 promoter upsteam of the gene encoding ®re¯y luciferase (Milia et al., 1996) . LTR/CAT, containing the CAT gene under the control of the HIV-1 LTR, was used as transfection control.
IgG from OKT3 (ATCC) hybridoma supernatants were puri®ed on Mabtrap (Pharmacia, LKB, Uppsala, Sweden). HA-Shc and mutants thereof were immunoprecipitated using a mouse IgG2a anti-HA mAb (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and protein A Sepharose (Amersham Pharmacia Biotech Italia, Milan). Anti-HA immunoblots were carried out using the 12CA5 anti-HA mAb (Boehringer Mannheim Italia). Immunoprecipitates were probed either with horseradish peroxidase-conjugated anti-phosphotyrosine mAb (Upstate Biotechnology Inc., Boston, MA, USA) or with polyclonal antisera against Shc, ZAP-70 and Grb-2 (Santa Cruz Biotechnology, Santa Cruz, CA, USA). AntiErk2 and anti-p38 MAPK polyclonal antisera, and anti-Lck mAb, were purchased from Santa Cruz Biotechnology. AntiLck and anti-Sos1 polyclonal antibodies were purchased from Upstate Biotechnology. Anti-phospho-p38 polyclonal antibodies were purchased from New England Biolabs Inc. (Beverly, MA, USA).
Transfections, luciferase and CAT assays, and flow cytometry Transfections were carried out as described using a modi®ca-tion of the DEAE-dextran procedure (Baldari et al., 1993) . To minimize variability among samples, activations were carried out on aliquots of a single pool of transfected cells. In addition all samples were in duplicate. A plasmid encoding bacterial chloramphenicol acetyltransferase (CAT) under the control of the HIV LTR (0.4 mg per sample) was included in all cotransfections as a control of transfection eciency. Cells were allowed to recover for 22 h before activation and activated either with plastic, immobilized anti-CD3 mAb as described (Milia et al., 1996) or with a combination of PMA (100 ng/ml) and A23187 (500 ng/ml). Cells were collected 8 ± 10 h after activation and assayed for luciferase activity using the protocol from Promega (Madison, WI, USA). CAT assays were carried out as described (Baldari et al., 1993) using equal amounts of proteins for each sample. Thin layer chromatograms were scanned and chloramphenicol acetylation was quantitated using a Phosphorimager (Molecular Dynamics, Sunnyvale, CA, USA). Each experiment was repeated 3 ± 5 times. The expression vectors encoding HA-Shc, HA-Shc-MLS and HA-3FShc-MLS were introduced into Jurkat cells by electroporation and stably transfected cells were selected in medium containing 1 mg/ml G418 (Gibco BRL, Life Technologies Italia Srl). Expression of the HA-Shc chimeras was evaluated by immunoblotting of equal amouts of cell lysates with anti-HA mAb. Cells were analysed for TCR/CD3 surface expression using FITC-labeled anti-CD3 mAb and a FacsScan ow cytometer (Becton-Dickinson, San Jose, CA, USA).
Activations, immunoprecipitations, immunoblots and kinase assays
Activations were carried out as described (Milia et al., 1996) . Cells (5610 7 /sample) were lysed in 1% (v/v) Triton X-100 in 20 mM Tris-HCl pH 8, 150 mM NaCl (in the presence of 0.2 mg/ml sodium orthovanadate, 1 mg/ml leupeptin, 1 mg/ml aproteinin, 1 mg/ml pepstatin and 10 mM phenyl methyl sulphonyl¯uoride) and postnuclear extracts were immunoprecipitated using the appropriate monoclonal or polyclonal antibodies and protein A Sepharose. Molecular weight markers were purchased from Amersham (Buckinghamshire, UK). In vitro kinase assays of Erk2 speci®c immunoprecipitates were carried out in 20 ml 20 mM Tris-HCl pH 7.4, 10 mM MgCl 2 , 10 mM MnCl 2 , 50 mM ATP, 5 mCi [ 32 P]gATP for 20 min 308C, using 10 mg myelin basic protein (Sigma Italia) as a substrate. The reaction products were subjected to SDS ± PAGE, transferred to nitrocellulose and exposed to a Phosphorimager (Molecular Dynamics, Sunnyvale, CA, USA). The ®lters were subsequently analysed by immunoblot with anti-Erk2 antibodies to check that similar amounts of Erk2 were recovered in the immunoprecipitates.
Cell fractionation
The separation of membrane and cytoplasmic fractions was performed by the phase separation method using Triton X-114 (Bordier, 1981) . Brie¯y, 2610 6 cells were lysed in 240 ml of Triton X-114 lysis buer (1% Triton X-114, 10 mM Tris, pH 7.5) by incubation at 48C for 10 min. Cell debris was removed by centrifugation and 200 ml of the supernatant was layered onto 300 ml of 6% sucrose buer. The sample was then incubated at 338C for 3 min, during which time partition of the Triton X-114 and the aqueous phase occurs. The sample was then centrifuged at 300 g for 3 min to separate the two phases. The aqueous phase, containing the cytoplasmic fraction, was recovered from the top of the sucrose cushion while the Triton X-114 phase, containing the membrane fraction, was recovered as a small gelatinous pellet underneath the sucrose cushion. This fraction was then diluted to 200 ml with 10 mM Tris and the samples analysed by SDS ± PAGE immunoblotting.
Lipid rafts were puri®ed by density gradient centrifugation using a modi®cation of the protocol described by Montixi et al. (1998) . Cells (5610 7 /sample) were washed twice in PBS and resuspended in 450 ml buer A (25 mM Tris pH 7.5, 150 mM NaCl, 5 mM EDTA and protease inhibitors as above). After incubation for 30 min on ice, cells were broken in a Dounce homogenizer added with 50 ml Brij 58 10% in buer A. After a 1 h incubation on ice, the lysate was added with 900 ml 2 M sucrose in buer A, placed at the bottom of a 5-ml centrifuge tube and overlaid with 450 ml aliquots of decreasing concentrations of sucrose in buer A, from 0.9 M to 0.2 M (0.1 M steps). The gradient was centrifuged in a SW65 rotor for 17 h at 50 000 r.p.m. (247 000 g) at 48C. 500-ml fractions were collected, beginning from the top. Fractions 2 ± 5, containing the rafts, and 8 ± 9, containing the detergentsoluble proteins, were pooled, and proteins were concentrated as described (Wessel and Flugge, 1983) . Equal amounts of proteins from the detergent-resistant and detergent-soluble fractions were separated by SDS ± PAGE and processed for immunoblotting.
Abbreviations PTK, protein tyrosine kinase; TCR, T-cell antigen receptor; MAP, mitogen activated protein; ITAM, immunoreceptor tyrosine-based activation motif; PTB, phosphotyrosine binding; CH, collagen homology; PMA, phorbol myristate acetate
